Skip to main content Accessibility help

Erythrocyte membrane trans-fatty acid index is positively associated with a 10-year CHD risk probability

  • Xiao-Ru Liu (a1) (a2), Ze-Yuan Deng (a1) (a2), Jiang-Ning Hu (a1), Ya-Wei Fan (a1), Rong Liu (a1), Jing Li (a1), Jing-Tian Peng (a3), Hai Su (a4), Qiang Peng (a4) and Wei-Feng Li (a3)...


Industry-generated trans-fatty acids (TFA) are detrimental to risk of CHD, but ruminant-originated TFA have been reported as neutral or equivocal. Therefore, the total TFA amount should not be the only factor considered when measuring the effects of TFA. In the present study, we addressed whether a version of the TFA index that unifies the effects of different TFA isomers into one equation could be used to reflect CHD risk probability (RP). The present cross-sectional study involved 2713 individuals divided into four groups that represented different pathological severities and potential risks of CHD: acute coronary syndrome (ACS, n 581); chronic coronary artery disease (CCAD, n 631); high-risk population (HRP, n 659); healthy volunteers (HV, n 842). A 10-year CHD RP was calculated. Meanwhile, the equation of the TFA index was derived using five TFA isomers (trans-16 : 1n-7, trans-16 : 1n-9, trans-18 : 1n-7, trans-18 : 1n-9 and trans-18 : 2n-6n-9), which were detected in the whole blood, serum and erythrocyte membranes of each subject. The TFA index and the 10-year CHD RP were compared by linear models. It was shown that only in the erythrocyte membrane, the TFA isomers were significantly different between the groups. In the ACS group, industry-generated TFA (trans-16 : 1n-9, trans-18 : 1n-9 and trans-18 : 2n-6n-9) were the highest, whereas ruminant-originated TFA (trans-16 : 1n-7 and trans-18 : 1n-7), which manifested an inverse relationship with CHD, were the lowest, and vice versa in the HV group. The TFA index decreased progressively from 7·12 to 5·06, 3·11 and 1·92 in the ACS, CCAD, HRP and HV groups, respectively. The erythrocyte membrane TFA index was positively associated with the 10-year CHD RP (R2 0·9981) and manifested a strong linear correlation, which might reflect the true pathological severity of CHD.


Corresponding author

*Corresponding author: Professor Z.-Y. Deng, fax +86 791 88304402, email


Hide All
1Shearer, GC, Pottala, JV, Spertus, JA, et al. (2009) Red blood cell fatty acid patterns and acute coronary syndrome. PLoS One 4, e5444.
2Hunter, JE, Zhang, J & Kris-Etherton, PM (2010) Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 91, 4663.
3Moyers, B, Farzaneh-Far, R, Harris, WS, et al. (2011) Relation of whole blood n-3 fatty acid levels to exercise parameters in patients with stable coronary artery disease (from the heart and soul study). Am J Cardiol 107, 11491154.
4Chavarro, JE, Stampfer, MJ, Campos, H, et al. (2008) A prospective study of trans-fatty acid levels in blood and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 17, 95101.
5Chajes, V, Thiebaut, ACM, Rotival, M, et al. (2008) Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC study. Am J Epidemiol 167, 13121320.
6Benatar, JR, Gladding, P, White, HD, et al. (2011) Trans-fatty acids in New Zealand patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 18, 615620.
7Lemaitre, RN, King, IB, Sotoodehnia, N, et al. (2010) Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. Metabolism 59, 10291034.
8Oomen, CM, Ocke, MC, Feskens, EJM, et al. (2001) Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357, 746751.
9Sun, Q, Ma, J, Campos, H, et al. (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115, 18581865.
10Smith, BK, Robinson, LE, Nam, R, et al. (2009) Trans-fatty acids and cancer: a mini-review. Br J Nutr 102, 12541266.
11Bendsen, NT, Stender, S, Szecsi, PB, et al. (2011) Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women. J Lipid Res 52, 18211828.
12Mozaffarian, D (2008) Commentary: ruminant trans fatty acids and coronary heart disease – cause for concern. Int J Epidemiol 37, 182184.
13Rungapamestry, V, McMonagle, J, Reynolds, C, et al. (2012) Inter-organ proteomic analysis reveals insights into the molecular mechanisms underlying the anti-diabetic effects of cis-9, trans-11-conjugated linoleic acid in ob/ob mice. Proteomics 12, 461476.
14Cassar, A, Holmes, DR, Rihal, CS, et al. (2009) Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc 84, 11301146.
15Alpert, JS, Antman, E, Apple, F, et al. (2000) Myocardial infarction redefined – a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36, 959969.
16Khot, UN, Jia, G, Moliterno, DJ, et al. (2003) Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA 290, 21742181.
17Gibbons, RJ, Abrams, J, Chatterjee, K, et al. (2003) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina – summary article – a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). Circulation 107, 149158.
18O'Rourke, RA, Brundage, BH, Froelicher, VF, et al. (2000) American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 36, 326340.
19Niu, S, Zhao, D, Zhu, J, et al. (2009) The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project. Am Heart J 157, 709.e1715.e1.
20Burton, GW, Ingold, KU & Thompson, KE (1981) An improved procedure for the isolation of ghost membranes from human red-blood-cells. Lipids 16, 946946.
21Cruz-Hernandez, C, Deng, ZY, Zhou, JQ, et al. (2004) Methods for analysis of conjugated linoleic acids and trans-18 : 1 isomers in dairy fats by using a combination of gas chromatography, silver-ion thin-layer chromatography/gas chromatography, and silver-ion liquid chromatography. J AOAC Int 87, 545562.
22Zghibeh, CM, Gopal, VR, Poff, CD, et al. (2004) Determination of trans-arachidonic acid isomers in human blood plasma. Anal Biochem 332, 137144.
23Kinlay, S, Oconnell, D, Evans, D, et al. (1992) The validity of estimating heart-disease reduction from a Framingham logistic equation. J Clin Epidemiol 45, 553560.
24Lin, DY, Wei, LJ & Ying, Z (1993) Checking the Cox model with cumulative sums of Martingale-based residuals. Biometrika 80, 557572.
25Harrell, FE, Lee, KL & Mark, DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15, 361387.
26Sepulveda, JL, Tanhehco, YC, Frey, M, et al. (2010) Variation in human erythrocyte membrane unsaturated fatty acids correlation with cardiovascular disease. Arch Pathol Lab Med 134, 7380.
27Katan, MB, Deslypere, JP, vanBirgelen, APJM, et al. (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 38, 20122022.
28Pittman, JG & Martin, DB (1966) Fatty acid biosynthesis in human erythrocytes: evidence in mature erythrocytes for an incomplete long chain fatty acid synthesizing system. J Clin Invest 45, 165172.
29Micha, R, King, IB, Lemaitre, RN, et al. (2010) Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr 91, 883893.
30Chiuve, SE, Rimm, EB, Manson, JE, et al. (2009) Intake of total trans, trans-18 : 1, and trans-18 : 2 fatty acids and risk of sudden cardiac death in women. Am Heart J 158, 761767.
31Or-Rashid, MM, Wright, TC & McBride, BW (2009) Microbial fatty acid conversion within the rumen and the subsequent utilization of these fatty acids to improve the healthfulness of ruminant food products. Appl Microbiol Biotechnol 84, 10331043.
32Turpeinen, AM, Mutanen, M, Aro, A, et al. (2002) Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76, 504510.
33Komori, H, Arai, H, Kashima, T, et al. (2008) Coexpression of CLA-1 and human PDZK1 in murine liver modulates HDL cholesterol metabolism. Arterioscler Thromb Vasc Biol 28, 12981303.
34Gomez-Cortes, P, Tyburczy, C, Brenna, JT, et al. (2009) Characterization of cis-9 trans-11 trans-15 C18 : 3 in milk fat by GC and covalent adduct chemical ionization tandem MS. J Lipid Res 50, 24122420.
35Bassett, CMC, McCullough, RS, Edel, AL, et al. (2009) Trans-fatty acids in the diet stimulate atherosclerosis. Metabolism 58, 18021808.
36Bassett, CMC, Edel, AL, Patenaude, AF, et al. (2010) Dietary vaccenic acid has antiatherogenic effects in LDLr − / −  mice. J Nutr 140, 1824.
37Wang, Y, Jacome-Sosa, MM, Ruth, MR, et al. (2009) Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp rats. J Nutr 139, 20492054.
38Blewett, HJ, Gerdung, CA, Ruth, MR, et al. (2009) Vaccenic acid favourably alters immune function in obese JCR:LA-cp rats. Br J Nutr 102, 526536.
39de Lorgeril, M & Salen, P (2004) Use and misuse of dietary fatty acids for the prevention and treatment of coronary heart disease. Reprod Nutr Develop 44, 283288.
40Abbey, M & Nestel, PJ (1994) Plasma cholesteryl ester transfer protein-activity is increased when trans-elaidic acid is substituted for cis-oleic acid in the diet. Atherosclerosis 106, 99107.
41Katan, MB, Zock, PL & Mensink, RP (1995) Trans-fatty-acids and their effects on lipoproteins in humans. Annu Rev Nutr 15, 473493.
42Williams, PT (2012) Fifty-three year follow-up of coronary heart disease versus HDL2 and other lipoproteins in Gofman's Livermore Cohort. J Lipid Res 53, 266272.
43Harvey, KA, Arnold, T, Rasool, T, et al. (2008) Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br J Nutr 99, 723731.
44Bionaz, M, Thering, BJ & Loor, JJ (2012) Fine metabolic regulation in ruminants via nutrient–gene interactions: saturated long-chain fatty acids increase expression of genes involved in lipid metabolism and immune response partly through PPAR-alpha activation. Br J Nutr 107, 179191.
45Sanadgol, N, Mostafaie, A, Bahrami, G, et al. (2010) Elaidic acid sustains LPS and TNF-alpha induced ICAM-1 and VCAM-I expression on human bone marrow endothelial cells (HBMEC). Clin Biochem 43, 968972.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Type Description Title
Supplementary materials

Liu Supplementary Material
Supplementary Material

 PDF (95 KB)
95 KB


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed